Prevalence and incidence of multiple sclerosis in Tehran, Iran

Iranian Journal of Public Health

Volumn 46, Issue 5, 2017, Pages 699-704

  Eskandarieh, Sharareh ^a,b   Heydarpour, Pouria ^b   Elhami, Seyedeh Robab ^c   Sahraian, Mohammad Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Incidence; Joinpoint regression; Multiple sclerosis; Prevalence

Indexed keywords

EID: 85019105597     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Koch-Henriksen N, Sørensen P (2010). The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol, 9:520-32.
2. Melcon M, Correale J, Melcon C (2014). Is it time for a new global classification of multiple sclerosis? J Neurol Sci, 344(1-2):171-81.
3. Dua T, Romani P (2008). Atlas of Multiple Sclerosis Resources in the World, WHO, Geneva.
4. Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA (2015). Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis. Neuroepidemiology, 44(4):232-244.
5. Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian M, Nasr Z (2014). Estimated Prevalence and Incidence of Multiple Sclerosis in Iran. Eur Neurol 72:370-74.
6. Compston A, Coles A (2002). Multiple sclerosis. Lancet, 359:1221-31.
7. Sawcer S (2008). The complex genetics of multiple sclerosis: pitfalls and prospects. Brain, 131:3118-31.
8. Elhami SR, Mohammad K, Sahraian MA, Eftekhar H (2011). A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology, 36:141-7.
9. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H (2010). Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol, 64:331-6.
10. Heydarpour P, Mohammad K, Yekaninejad MS, Elhami SR, Khoshkish S, Sahraian MA (2014). Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis. Mult Scler, 20:512.
11. McDonald WI, Compston A, Edan G et al (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50:121-7.
12. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol, 13:227-31.
13. Jemal A, Ward E, Thun MJ (2007). Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res, 9(3):R28.
14. O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S (2008). Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart, 94:178-81.
15. Leslie WD, O'Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A, Osteoporosis Surveillance Expert Working G (2009). Trends in hip fracture rates in Canada. JAMA, 302:883-9.
16. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24:4539-44.
17. Al-Hashel J, Besterman AD, Wolfson C (2008). The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology, 31:129-37.
18. Etemadifar M, Maghzi AH (2011). Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler, 17:1022-7.
19. Ghandehari K, Riasi HR, Nourian A, Boroumand AR (2010). Prevalence of multiple sclerosis in north east of Iran. Mult Scler, 16:1525-6.
20. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S (2013). Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg, 115:304-8.
21. Wallin MT, Page WF, Kurtzke JF (2004). Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol, 55:65-71.
22. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG (2003). Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci, 213:1-6.
23. Chitnis T, Glanz B, Jaffin S, Healy B (2009). Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler, 15:627-31.
24. Al Jumah M, Kojan S, Al Khathaami A, Al Abdulkaream I, Al Blawi M, Jawhary A (2011). Familial multiple sclerosis: does consanguinity have a role? Mult Scler, 17:487-9.
25. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F (2006). Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology, 27:39-44.
26. Hashemilar M SOD, Farhoudi M,Ayromlou H, Asadollahi A (2011). Multiple sclerosis in east Azerbaijan, north west Iran. Neurology Asia, 16:127-131.
27. Kalanie H, Gharagozli K, Kalanie AR (2003). Multiple sclerosis: report on 200 cases from Iran. Mult Scler, 9:36-8.
28. Rezaali S, Khalilnezhad A, Naser Moghadasi A, Chaibakhsh S, Sahraian MA (2013). Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iran J Neurol, 12:136-43.
29. Al-Afasy HH, Al-Obaidan MA, Al-Ansari YA, Al-Yatama SA, Al-Rukaibi MS, Makki NI, Suresh A, Akhtar S (2013). Risk factors for multiple sclerosis in Kuwait: a population-based case-control study. Neuroepidemiology, 40:30-5.
30. Deleu D, Mir D, Al Tabouki A et al (2013). Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler, 19:816-9.